ClinicalTrials.Veeva

Menu

Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery

J

Jilin University

Status

Unknown

Conditions

Diverting Ileostomy
Middle and Low Rectal Cancer
Functional Outcome
Stoma Complications

Treatments

Procedure: Diverting ileostomy

Study type

Observational

Funder types

Other

Identifiers

NCT04776421
STARS-RC02

Details and patient eligibility

About

Analyze the occurrence of complications, rectal function and quality of life after anus-preserving surgery for middle and low rectal cancer, so as to evaluate the role of protective ileostomy.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Necessary conditions: meet one of the following conditions

  1. Difficult pelvis: narrow pelvis (diameter of ischial tuberosity <10 cm, diameter of ischial spine <12 cm) 13 or BMI≥30kg/m2 or tumor diameter≥5cm2.
  2. To receive treatment before surgery: preoperative neoadjuvant radiotherapy or concurrent chemoradiation or ESD
  3. The anastomosis is below the level of the levator ani muscle: such as ISR, TaTME surgery, etc.

Other conditions:

  1. Age: 18 to 75 years old, male or female;
  2. Preoperative biopsy pathological diagnosis of rectal adenocarcinoma;
  3. Received MRI evaluation before surgery, and the distance between the lower edge of the tumor and the anal edge is no more than 10cm;
  4. The clinical stage is T1-3N0-2M0;
  5. Undertake elective laparoscopic TME for colon-rectal or colon-anal anastomosis
  6. ECOG score 0-2;
  7. Heart, lung, liver, and kidney functions can tolerate surgery;
  8. Patients and their families can understand and are willing to participate in this clinical study, and sign informed consent.

Exclusion criteria

  1. Past history of malignant colorectal tumors or recent diagnosis combined with other malignant tumors;
  2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery;
  3. Neighboring organs need to be combined with organ removal
  4. ASA grade ≥ grade IV and/or ECOG physical status score> 2 points;
  5. Those who have severe liver and kidney function, cardiopulmonary function, blood coagulation dysfunction, or combined with serious underlying diseases that cannot tolerate surgery;
  6. Have a history of severe mental illness;
  7. Pregnant or lactating women;
  8. Those with a history of taking hormone drugs;
  9. Patients with other clinical and laboratory conditions considered by the investigator should not participate in the trial.

Trial design

300 participants in 1 patient group

ileostomy group
Treatment:
Procedure: Diverting ileostomy

Trial contacts and locations

0

Loading...

Central trial contact

Weihua Tong; Quan Wang, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems